Why test antiplatelet therapy in acute ischaemic stroke and how can this be done?
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 1461865.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stroke is a major public health problem, yet there is no treatment of proven value for widespread use in the acute phase of the illness. This paper outlines the rationale for using antiplatelet therapy in acute ischaemic stroke and why it appears to be one of the most promising agents for testing in very large scale clinical trials.
Medical subject headings
- Brain Ischemia
- Platelet Aggregation Inhibitors